FDA and CBD

A bipartisan bill that was introduced in the U.S. House of Representatives Thursday could push legal CBD through Congress, providing consumer access and protection while clearing the supply chain bottleneck. The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 is sponsored by Representatives Kurt Schrader, a Democrat from Oregon, and Morgan
U.S. health officials are asking for research about how hemp-derived cannabinoids and other plant-derived treatments affect chronic pain. The Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human Services, opened a four-week call for submission Wednesday. They’re conducting a systematic review on pain to “produce evidence to make health
Federal health authorities want to discuss gender differences in the effects of CBD and other cannabinoids. The U.S. Food and Drug Administration’s Office of Women’s Health announced a Nov. 19 “multidisciplinary scientific conference” for medical professionals and members of the public to talk about how genders might be affected differently by cannabinoids. The agency says
The biggest question mark for the global CBD industry right now is not how to market the cannabinoid and what it can do. Instead, the biggest question mark is whether the hemp and marijuana industries will be allowed to show customers what CBD can do. Ongoing legal questions about the cannabis extract – which is
Two scientists will lead a third-party consumer research study on the effects of regular CBD use on humans, particularly focused on liver safety. Dr. Keith Aqua, a Miami-based medical doctor, and Dr. Jeff Lombardo, a Buffalo, New York-based pharmacist who specializes in toxicology, are the co-principal investigators for a national clinical trial measuring the potential
Over-the-counter CBD isn’t legal and continues to worry federal drug regulators as more people take it and give it to animals, a lawyer for the U.S. Food and Drug Administration said Friday. Randall Gnatt, senior counsel at the FDA, told the nation’s veterinarians that the FDA thinks there are “data gaps and safety concerns” about
Officials from the National Credit Union Administration have outlined additional information on serving legal hemp businesses. A letter issued this week points out that hemp-related businesses have also been affected by the COVID-19 pandemic and that it is “important that credit unions stay current with the federal, state and Native American tribal laws and regulations
Colorado and Illinois are joining the ranks of nearly a dozen states where CBD and other hemp-derived products can be sold at marijuana dispensaries for the first time, opening a new sales outlet for the growing industry. In the absence of guidance from the U.S. Food and Drug Administration, states are taking their own approaches
In just two years, the number of specialty pet stores that carried Colorado-based Functional Remedies’ CBD products increased dramatically, going from 100 to 500 – underscoring the fast growth of a market that’s now reaching mass-market retailers like Petco and PetSmart. “More and more people are understanding how CBD and how hemp-based products can enhance
Another CBD company has issued a voluntary product recall after the U.S. Food and Drug Administration flagged it for making unsubstantiated claims. Biota Biosciences, a Seattle-based CBD manufacturer, is recalling lots from three injectable products sold by distributors to consumers that were being marketed without FDA approval: Cannabidiol (CBD) Complex, marketed to suppress pain and
Even before the coronavirus pandemic, CBD and herbal product manufacturers were getting in trouble with the U.S. Food and Drug Administration for making unsubstantiated claims about their products. But the coronavirus has ushered in more dubious claims – and more warning letters from the FDA directing companies to immediately stop. The letters have hit businesses across
The U.S. Food and Drug Administration has updated its guidance for reporting adverse effects of various products, including dietary supplements, during the coronavirus pandemic. The FDA does not consider CBD a dietary supplement. But many CBD manufacturers do and follow FDA guidance on making and selling dietary supplements. The agency made the announcement this month, saying
The U.S. Food and Drug Administration said it will continue to “take appropriate action against unlawful CBD products that pose a risk of harm to the public,” even as the federal agency implored the industry to collaborate with the government to study CBD’s possible benefits and dangers. The statement Thursday from new FDA Commissioner Dr.